This report assembles a global sector overview, including details on financings, partnerships and other deals, clinical trial information, major clinical data events, and ARM’s current legislative and regulatory priorities.
Regenerative Medicine Companies
Worldwide, Including Gene and
Cell Therapies, and Tissue Engineering
Increase from Q1 2017
Clinical trials underway
worldwide by the end of Q1 2018
View Full Report View Past Reports